The company is demonstrably boosted its progress of an new therapy for ATTR-CM, leveraging the investigational drug. Early patient information reveals significant benefits for those diagnosed with this serious illness. https://attrcm851394.angelinsblog.com/40863192/bridgebio-advances-amyloidosis-management-through-the-drug